Cargando…
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer
Purpose: Advanced prostate cancer (PCa) has limited treatment regimens and shows low response to chemotherapy and immunotherapy, leading to poor prognosis. Histone modification is a vital mechanism of gene expression and a promising therapy target. In this study, we characterized WD repeat domain 5...
Autores principales: | Zhou, Qianghua, Chen, Xu, He, Haixia, Peng, Shengmeng, Zhang, Yangjie, Zhang, Jingtong, Cheng, Liang, Liu, Sen, Huang, Ming, Xie, Ruihui, Lin, Tianxin, Huang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978315/ https://www.ncbi.nlm.nih.gov/pubmed/33754029 http://dx.doi.org/10.7150/thno.55814 |
Ejemplares similares
-
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer
por: Zhang, Jingtong, et al.
Publicado: (2021) -
TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination
por: Zhou, Qianghua, et al.
Publicado: (2023) -
WD repeat domain 48 promotes hepatocellular carcinoma progression by stabilizing c‐Myc
por: Li, Bo, et al.
Publicado: (2022) -
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program
por: Huang, Ming, et al.
Publicado: (2022) -
UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancer
por: Peng, Shengmeng, et al.
Publicado: (2022)